Efficacy and safety of 177Lu-DOTMP in palliative treatment of symptomatic skeletal metastases: a prospective study-Reference-Cited by-同舟云学术

Efficacy and safety of 177Lu-DOTMP in palliative treatment of symptomatic skeletal metastases: a prospective study

Published:2021-05-19 Issue:9 Volume:42 Page:964-971
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Bollampally Neeraja,Shukla Jaya,Mittal Bhagwant Rai,Sood Ashwani,Mohanty Manju,Kapoor Rakesh,Vatsa Rakhee,Satapathy Swayamjeet,Chakravarty Rubel,Chakraborty Sudipta,Dash Ashutosh K

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference20 articles.

1. The science behind metastatic bone pain.;Mantyh;Eur J Cancer Suppl,2006

2. Improving quality of life in patients with advanced cancer: targeting metastatic bone pain.;von Moos;Eur J Cancer,2017

3. Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain.;Paes;Semin Nucl Med,2010

4. Radionuclide therapy for osseous metastases in prostate cancer.;Abi-Ghanem;Semin Nucl Med,2015

5. A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases.;Poulter;Int J Radiat Oncol Biol Phys,1992

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kemik Metastazlarının Tedavisinde Radyofarmasötiklerin Rolü;Fabad Journal of Pharmaceutical Sciences;2023-05-02

2. 177Lu-EDTMP radiation absorbed dose evaluation in man based on biodistribution data in Wistar rats;Nuclear Engineering and Technology;2023-01

3. Evolution of chemistry programme at DAE;Current Science;2022-08-10